Please use this identifier to cite or link to this item: http://hdl.handle.net/1783.1/1324

Elucidation of the c-Jun N-terminal kinase pathway mediated by Epstein-Barr virus-encoded latent membrane protein

Authors Wan, J
Sun, LG
Mendoza, JW
Chui, YL
Huang, DP
Chen, ZJJ
Suzuki, N
Suzuki, S
Yeh, WC
Akira, S
Matsumoto, K
Liu, ZG
Wu, ZG
Issue Date 2004
Source Molecular and cellular biology , v. 24, (1), 2004, JAN, p. 192-199
Summary Epstein-Barr virus (EBV) is associated with several human diseases including infectious mononucleosis and nasopharyngeal carcinoma. EBV-encoded latent membrane protein 1 (LMP1) is oncogenic and indispensable for cellular transformation caused by EBV. Expression of LMP1 in host cells constitutively activates both the c-Jun N-terminal kinase (JNK) and NF-kappaB pathways, which contributes to the oncogenic effect of LMP1. However, the underlying signaling mechanisms are not very well understood. Based mainly on overexpression studies with various dominant-negative constructs, LMP1 was generally thought to functionally mimic members of the tumor necrosis factor (TNF) receptor superfamily in signaling. In contrast to the prevailing paradigm, using embryonic fibroblasts from different knockout mice and the small interfering RNA technique, we find that the LMP1-mediated JNK pathway is distinct from those mediated by either TNF-alpha or interleukin-1. Moreover, we have further elucidated the LMP1-mediated JNK pathway by demonstrating that LMP1 selectively utilizes TNF receptor-associated factor 6, TAK1/TAB1, and c-Jun N-terminal kinase kinases 1 and 2 to activate JNK.
Subjects
ISSN 0270-7306
Rights Copyright © American Society for Microbiology [Molecular and Cellular Biology, v. 24, no. 1, Jan. 2004, p. 192-199]
Language English
Format Article
Access View full-text via DOI
View full-text via Web of Science
View full-text via Scopus
Find@HKUST
Files in this item:
File Description Size Format
microbio.pdf 1345257 B Adobe PDF